[ad_1] DURHAM, N.C., Sept. 25, 2024 /PRNewswire/ — EydisBio, Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to EYD-001, its highly selective and potent, orally […]